Skip to main content

Table 4 Econometric results

From: Discrete-choice modelling of patient preferences for modes of drug administration

Dependent variable: CHOICE PROBABILITY

 

MNL model

HMNL model

EMNL model

MMNL model

LCMNL model

Variables/Coefficients:

\( \widehat{\upbeta}(SE) \)

\( \widehat{\upbeta} \)(SE)

\( \widehat{\upbeta}(SE) \)

\( \widehat{\upbeta_{\mathrm{s}}}(SE) \)

\( {\widehat{\upbeta}}_1(SE) \)

\( {\widehat{\upbeta}}_2(SE) \)

INTRAVENOUS

−0.011 (0.091)

0.005 (0.057)

0.017 (0.042)

−0.026 (0.110)

−0.119 (0.439)

0.021 (0.123)

SUBCUTANEOUS

0.021 (0.043)

0.016 (0.027)

0.002 (0.019)

−0.016 (0.049)

−0.073 (0.130)

0.070 (0.060)

INTRAMUSCULAR

−0.136 (0.049)**

−0.090 (0.031)**

−0.111 (0.037)**

−0.123 (0.053)*

−0.560 (0.210)**

−0.219 (0.064)***

DOSFREQ

−0.001 (0.000)***

−0.0005 (0.000)***

−0.001 (0.000)**

−0.001 (0.000)***

−0.003 (0.001)***

−0.001 (0.000)**

NONCLINICAL_SELF

0.167 (0.037)***

0.108 (0.025)***

0.112 (0.038)**

0.210 (0.039)***

0.424 (0.128)***

0.146 (0.045)**

NONCLINICAL_SUPV

−0.122 (0.028)***

−0.078 (0.019)***

−0.067 (0.025)**

−0.120 (0.030)***

−0.124 (0.093)

−0.098 (0.037)**

DDA_MODERATE1

0.391 (0.033)***

0.239 (0.033)***

0.214 (0.074)**

0.437 (0.038)***

1.210 (0.150)***

0.264 (0.050)***

DDA_MODERATE2

−0.267 (0.042)***

−0.171 (0.032)***

−0.167 (0.059)**

−0.300 (0.046)***

−1.058 (0.141)***

−0.075 (0.061)

DDA_SEVERE

−0.525 (0.039)***

−0.336 (0.044)***

−0.308 (0.103)**

−0.588 (0.044)***

−1.376 (0.184)***

−0.324 (0.057)***

RAE_MODERATE

0.169 (0.034)***

0.108 (0.024)***

0.111 (0.041)**

0.212 (0.038)***

0.522 (0.141)***

0.067 (0.043)

RAE_SEVERE

−0.743 (0.039)***

−0.461 (0.056)***

−0.406 (0.138)**

−0.869 (0.044)***

−2.342 (0.215)***

−0.204 (0.059)***

COST

−0.008 (0.001)***

−0.005 (0.001)***

−0.004 (0.001)**

−0.0118 (0.040)***

−0.012 (0.002)***

−0.008 (0.001)***

A

−0.054 (0.054)

−0.033 (0.034)

0.002 (0.025)

−0.073 (0.066)

0.370 (0.274)

−0.122 (0.073)!

Entropy\( \left(\widehat{\uptheta_1},\widehat{\uptheta_2}\right) \)

(1.026, 0.717)

 

\( {\widehat{\alpha}}_0 \)(FEMALE)

0.170 (0.035)***

 

\( {\widehat{\alpha}}_1 \)(VOCATIONAL)

−0.230 (0.085)**

 

\( {\widehat{\alpha}}_2 \)(GCSEs_O + A)

−0.199 (0.054)***

 

\( {\widehat{\pi}}_c \)

0.49

0.51

\( {\widehat{\gamma}}_c \)(VOCATIONAL)

−0.892 (0.324)**

\( {\widehat{\gamma}}_c \)(GCSEs_O + A)

0.577 (0.203)**

\( {\widehat{\gamma}}_c \)(FEMALE)

0.285 (0.122)*

\( {\widehat{\gamma}}_c \)(RESPONDENTAGE)

    

0.024 (0.009)**

 

Log-likelihood (AIC)

−2855.357 (5736.713)

−2812.19 (5670.381)

−2837.971 (5670.381)

−2782.51 (5611.019)

−2652.879 (5379.757)

 
  1. Notes: SE = standard error. For the HMNL and LCMNL models, we report selected effects of respondent-characteristics on the scale-parameter and latent-class membership. MMNL model was estimated using 500 Halton draws of correlated normally-distributed coefficients for the variables A, INTRAVENOUS and SUBCUTANEOUS and a log-normal distributed cost coefficient. *** p < 0.001 ** p < 0.01 * p < 0.05! p < 0.10. AIC = Akaike Information Criterion